Cargando…
Rising CNS Polypharmacy Among Older Adults in the United States
CNS-polypharmacy is defined by the AGS Beers Criteria as using 3 or more individual medications from the following classes: antidepressants, antipsychotics, benzodiazepines, other sedative/hypnotics, opioids, antiepileptics. Dr. Maust will review data suggesting that such prescribing has increased a...
Autor principal: | Maust, Donovan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743137/ http://dx.doi.org/10.1093/geroni/igaa057.2689 |
Ejemplares similares
-
Factors Associated With Loneliness During the COVID-19 Pandemic Among Older Adults With Chronic Conditions
por: Polenick, Courtney, et al.
Publicado: (2020) -
Polypharmacy in the Older Adult: Medication Review in the Community
por: Pacetti, Staci, et al.
Publicado: (2020) -
Nurse Practitioners’ Experiences of Polypharmacy in Community-Dwelling Older Adults
por: Pariseault, Christine, et al.
Publicado: (2020) -
Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States
por: Sheikh-Taha, Marwan, et al.
Publicado: (2021) -
Adverse Outcomes, Polysubstance Use, and Polypharmacy in Older Veterans
por: Byers, Amy
Publicado: (2020)